New insights into the older hypoglycemic agents in type 2 diabetes therapy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.13096
Abstract: Type 2 diabetes (T2D) is one of the leading causes of morbidity and mortality, consuming a significant proportion of public health spending. Following lifestyle changes, the most common treatment for T2D is the addition of… read more here.
Keywords: agents type; type diabetes; new insights; insights older ... See more keywords